|
全国免费电话：400-668-6834 -- 仅限中国地区 -- |
在线订购：QQ: 4006686834 电话订购：021-68591985 邮件订购：info@selleck.cn 我们也提供销售人员上门服务 |
技术支持电话：400-168-6834 我们将于一个工作日与您联系 |
Tiragolumab (anti-TIGIT)
目录号：A2028 批次号: A202804
Tiragolumab (anti-TIGIT) (RG6058, MTIG7192A) 是一种人源化 IgG1/kappa 单克隆抗体，可与 TIGIT 结合以防止其与其配体 PVR (CD155) 相互作用。
抗体信息
| CAS号 | 1918185-84-8 |
|---|---|
| 推荐同型对照 | Human IgG1, κ |
| 来源 | CHO cells |
| 储存条件 (自收到货起) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles. |
| 除菌 | 0.2 μM filtered |
| 纯度 | 99% |
| 蛋白浓度 | 4.41mg/ml |
| 内毒素 | ＜1EU/mg |
Tiragolumab (anti-TIGIT)在文献中得到引用
| Combined dendritic cell and anti-TIGIT immunotherapy potentiates adaptive NK cells against HIV-1 [ EMBO Mol Med, 2025, 10.1038/s44321-025-00255-x] | PubMed: 40473838 |
| Combined dendritic cell and anti-TIGIT immunotherapy potentiates adaptive NK cells against HIV-1 [ EMBO Molecular Medicine, 2025, 1-20] | PubMed: 40473838.0 |
| Unlocking the potential of TIGIT in enhancing therapeutic strategies for acute myeloid leukemia through combined azacitidine therapy [ NPJ Precis Oncol, 2025, 9(1):142] | PubMed: 40374899 |
| Novel insights into immune checkpoints in HIV/SHIV infection: from SHIVSF162P3-infected elite controllers to therapeutic strategy [ J Virol, 2025, 99(8):e0078525] | PubMed: 40637373 |
| Dual targeting of CD155/TIGIT and PD-L1/PD-1 immune checkpoints potentiates NK cell-mediated cytotoxicity in medulloblastoma [ Neuro-Oncology Advances, 2025, vdaf099] | PubMed: 40703802.0 |
| Dual targeting of CD155/TIGIT and PD-L1/PD-1 immune checkpoints potentiates NK cell-mediated cytotoxicity in medulloblastoma [ Neurooncol Adv, 2025, 7(1):vdaf099] | PubMed: 40703802 |
| Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer [ Cancer Cell, 2024, 2045-2063.e10] | PubMed: 39658541.0 |
| Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer [ Cancer Cell, 2024, 42(12):2045-2063.e10] | PubMed: 39658541 |
| Inhibition of Cbl-b restores effector functions of human intratumoral NK cells [ Journal for ImmunoTherapy of Cancer, 2024, e009860] | PubMed: 39551607.0 |
| Inhibition of Cbl-b restores effector functions of human intratumoral NK cells [ J Immunother Cancer, 2024, 12(11)e009860] | PubMed: 39551607 |
禁止用于人体及治疗！